The term “DIDMOAD” syndrome – an acronym for the characteristic symptoms – serves as an alternative name for this autosomal recessive neurodegenerative disease, which was first described in 1938: Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy and Deafness/Deafness. In the majority of patients, mutations in the WFS1 gene can be detected.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- SGLT2 inhibitors
Clear, simple language improves patient safety
- Moderate to severe atopic dermatitis
Established and novel biologics – the therapeutic landscape is in flux
- Recognize CKD early and avoid dialysis
Screen diabetics and hypertensive patients regularly and use modern therapies
- From symptom to diagnosis
Abdominal pain – Inguinal testicles
- Case series
Mast cell activation syndrome (MCAS)
- Gestational diabetes
Significant CVD prevention through five lifestyle factors
- Modern therapeutic approaches for melanoma
Innovative strategies to overcome immunotherapy resistance
- Irritable Bowel Syndrome